News Image

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Aug 7, 2025

– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 –

– Data readouts for CHS-114 and casdozokitug on track for 1H 2026 –

Read more at globenewswire.com

COHERUS ONCOLOGY INC

NASDAQ:CHRS (9/12/2025, 6:01:33 PM)

After market: 1.29 0 (0%)

1.29

-0.04 (-3.01%)



Find more stocks in the Stock Screener

Follow ChartMill for more